Richard J. Linder

Prior to founding Xenter, Mr. Linder served as the Chairman/Chief Executive Officer of CoNextions Medical, a company he founded to specialize in the development and manufacture of medical devices for Orthopaedic Surgery in tendon re-construction and tendon to bone anchoring. Prior to CoNextions, Mr. Linder served as President of the Cardiovascular Division of Remedy Informatics, a company providing medical registries of Electronic Health Record (EHR) data. Before Remedy, Mr. Linder served as President/CEO of Coherex Medical, Inc., a Salt Lake City, UT based medical device company specializing in the development of Patent Foramen Ovale (PFO) closure devices and Left Atrial Appendage (LAA) occlusion devices for use in patients with Atrial Fibrillation (AF) and Stroke. Mr. Linder negotiated and entered into agreements with Johnson & Johnson/Biosense Webster to invest in and acquire Coherex Medical.

Prior to Coherex, Mr. Linder served as Vice President of Vascular Protection for Boston Scientific/Rubicon Medical, and he served as President/CEO of Rubicon Medical, a company he Co-Founded. Mr. Linder Co-Founded Rubicon Medical in 1996, took the company public in 2000, and invented the underlying medical devices for the Rubicon Vascular Protection Filter for patients undergoing Carotid artery and Saphenous Vein Graft stenting.

Mr. Linder began his career at Merit Medical Systems, Inc., a South Jordan, UT publicly traded (Nasdaq) global medical device company. Mr. Linder is the Founder and Chairman Emeritus of BioUtah, Utah’s independent life science association representing Utah’s medical device companies, drug development and drug discovery companies, and diagnostic companies. Mr. Linder was appointed by the Utah Speaker of the House of Representatives to the Governing Authority of the Utah Science Technology and Research Initiative (USTAR), and Mr. Linder participated in the oversight of The James L. Sorenson Molecular Biotechnology Building A USTAR Innovation Center which houses the Nano Institute of Utah, many Utah Technology Commercialization Grants, and other activities. USTAR’s Governing Authority oversaw $430M in Utah taxpayer money and assisted the University of Utah and Utah State University in recruiting world class research programs to the State of Utah’s major public universities.

Mr. Linder has served as a member of the Board of Directors for the Boy Scouts of America (Salt Lake City, UT) and was the Executive Vice President of Finance. He has served on the Board of Directors for many private and public companies including Rubicon Medical, Coherex Medical, CoNextions Medical, Juneau BioScience, Vital Access Corp., and Dynatronics. He has been an invited speaker, meeting faculty, panelist, and Keynote speaker at Transcatheter Cardiovascular Therapeutics (TCT), American College of Cardiology (ACC), Dartmouth 3D, BioUtah Life Science Summit, and many other conferences and meetings. Mr. Linder attended both Brigham Young University and the University of Utah where he studied Business Management and Organizational Behavior. Mr. Linder is the inventor of many medical devices in Interventional Cardiology, Interventional Radiology, Neuro-Interventional Radiology, Orthopedic Surgery, Female Reproductive Medicine, and a Percutaneous Left Ventricular Assist Device (LVAD). He holds more than 100 patents and patent applications in the United States for medical devices, and many more international patents. Mr. Linder has been in many countries around the world and has overseen several multi-center clinical research trials for medical devices. Mr. Linder is the recipient of the Utah Governor’s Medal for Science & Technology.